Pogribny Igor P, Ross Sharon A, Tryndyak Volodymyr P, Pogribna Marta, Poirier Lionel A, Karpinets Tatiana V
National Center for Toxicological Research, Jefferson, AR 72078, National Cancer Institute, Bethesda, MD 20892 and University of Tennessee, Knoxville, TN 37996, USA.
Carcinogenesis. 2006 Jun;27(6):1180-6. doi: 10.1093/carcin/bgi364. Epub 2006 Feb 23.
The field of cancer epigenetics has received much attention in recent years. However, the relationship of cancer epigenetics with cancer etiology is not clear. Recent studies suggest the involvement of altered DNA methylation and histone modifications in the emergence of epigenetically reprogrammed cells with specific tumor-related phenotypes at premalignant stages of tumor development. In this study, we used a methyl-deficient model of rodent hepatocarcinogenesis to examine the roles of DNA, histone H3 lysine 9 and histone H4 lysine 20 methylation, and the level of the expression of Suv39h1 and Suv4-20h2 histone methyltransferases in the carcinogenic process. We demonstrated that the development of liver tumors was characterized by progressive demethylation of DNA repeats, decrease in histone H4 lysine 20 trimethylation, and a gradual decrease in the expression of Suv4-20h2 histone methyltransferase. A prominent increase in the trimethylation of histone H3 lysine 9 and in the expression of Suv39h1 histone methyltransferase was observed in preneoplastic nodules and liver tumors indicating the promotional role of these epigenetic alterations at later stages of carcinogenesis. The appearance of tumor-specific epigenetic alterations (demethylation of repetitive elements, loss of histone H4 lysine 20 trimethylation, altered expression of Suv4-20h2 and Suv39h1 histone methyltransferases) at preneoplastic stages of hepatocarcinogenesis provides experimental support for the epigenetic hypothesis of tumorigenesis that considers stress-induced epigenetic reprogramming of the cell as an important prerequisite to succeeding mutations.
近年来,癌症表观遗传学领域备受关注。然而,癌症表观遗传学与癌症病因之间的关系尚不清楚。最近的研究表明,在肿瘤发生的癌前阶段,DNA甲基化改变和组蛋白修饰参与了具有特定肿瘤相关表型的表观遗传重编程细胞的出现。在本研究中,我们使用啮齿动物肝癌发生的甲基缺乏模型,来研究DNA、组蛋白H3赖氨酸9和组蛋白H4赖氨酸20甲基化的作用,以及Suv39h1和Suv4 - 20h2组蛋白甲基转移酶的表达水平在致癌过程中的作用。我们证明,肝肿瘤的发展特征为DNA重复序列的逐渐去甲基化、组蛋白H4赖氨酸20三甲基化的减少以及Suv4 - 20h2组蛋白甲基转移酶表达的逐渐降低。在癌前结节和肝肿瘤中观察到组蛋白H3赖氨酸9三甲基化和Suv39h1组蛋白甲基转移酶表达显著增加,表明这些表观遗传改变在致癌后期具有促进作用。肝癌发生癌前阶段出现的肿瘤特异性表观遗传改变(重复元件去甲基化、组蛋白H4赖氨酸20三甲基化缺失、Suv4 - 20h2和Suv39h1组蛋白甲基转移酶表达改变)为肿瘤发生的表观遗传假说提供了实验支持,该假说认为应激诱导的细胞表观遗传重编程是后续突变的重要前提。